Ubs Asset Management Americas Inc Assembly Biosciences, Inc. Transaction History

Ubs Asset Management Americas Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $243,614 - $292,337	-64,109 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.33 - $6.63 $72,960 - $111,715	16,850 Added 35.65%	64,109 $294,000
Q4 2020 Mar 01, 2021	BUY	$4.87 - $17.29 $167,445 - $594,482	34,383 Added 267.03%	47,259 $285,000
Q3 2020 Nov 13, 2020	SELL	$15.08 - $27.04 $148,613 - $266,479	-9,855 Reduced 43.35%	12,876 $211,000
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $167,467 - $275,396	11,494 Added 102.29%	22,731 $530,000

Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $130,767 - $270,321	-12,733 Reduced 53.12%	11,237 $166,000
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $106,447 - $303,172	12,733 Added 113.31%	23,970 $490,000
Q1 2019 May 14, 2019	BUY	$17.7 - $24.93 $198,894 - $280,138	11,237 New	11,237 $0

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $647M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.